First-Line Carboplatin and Pemetrexed With Pembrolizumab for NSCLC

June 21, 2017
Leena Gandhi, MD, PhD

Leena Gandhi, MD, PhD, director of the Thoracic Medical Oncology Program at NYU Langone School of Medicine, discusses first-line carboplatin and pemetrexed with or without pembrolizumab for advanced nonsquamous non–small cell lung cancer.